EZH2 mutations have been described in numerous cancer types including melanoma, hematologic malignancies, breast cancer, prostate cancer, liver and biliary cancers, lung cancer, and endometrial cancer, while EZH2A692V hotspot mutations have been most commonly described in follicular lymphoma and diffuse large B cell lymphoma18–25. This evidence concerns the gene EZH2 and endometrial cancer.